New biosecurity centre to tackle pandemics and animal disease gets £1bn funding
The announcement is part of a new national security strategy being unveiled on Tuesday, and the facility will join a network of government laboratories to protect the public and respond to biological security risks.
The funding for the next phase of a biosecurity centre at Weybridge, Surrey, comes after warnings from the National Audit Office that the Government was not properly prepared for a major outbreak of animal disease.
Animal diseases such as bird flu, bluetongue and African swine fever can pose serious threats to England's farming sector, food security, and wildlife, and are a major and increasing risk to public health.
About 60% of all known human infectious diseases can be transmitted from animals to people, and three quarters of emerging infectious diseases originate in animals, officials warned.
The 'record' investment will complete the redevelopment of the crumbling animal science facilities at Weybridge, which the National Audit Office (NAO) recently warned was at 'very high' risk of site failure.
It aims to enhance detection, surveillance and control measures for high-risk animal diseases such as foot and mouth, officials said.
Environment Secretary Steve Reed said: 'The first role of any Government is national security.
'That is why we are making a record investment into the nation's biosecurity capabilities and, in turn, our national security, after years of chronic underfunding.
'Farmers and food producers will now be better protected from diseases, our food security strengthened, and public health better safeguarded against future pandemics.'
Jenny Stewart, senior science director at the Animal and Plant Health Agency, which runs the labs, said the funding was a 'vital milestone' in the delivery of the new facilities.
'Our scientists and specialists at Weybridge are at the heart of the UK's disease surveillance and response capability and provide a global centre of expertise.
'Investment on this scale will enable them to continue their critical work in modern, fit-for-purpose facilities, supported by the very latest technologies.'
The Government said work was already under way at the Weybridge site, with the first interim labs to support science ready in 2027 and 2028, and the national biosecurity centre due to be operational in 2033-34.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
STV News
15 minutes ago
- STV News
Judi Dench: Government must give people with dementia earlier diagnosis
Dame Judi Dench is calling on the Government to give people with dementia an earlier diagnosis on the NHS. The Oscar-winning actress is backing a new campaign and petition by Alzheimer's Research UK for people with the condition to be told much quicker if they have it. Almost a million people in the UK are living with dementia, but about one in three do not have a diagnosis. According to Alzheimer's Research UK, people in some parts of England can wait up to a year for a diagnosis after being referred, while those in the most deprived areas face longer delays. Dame Judi said: 'Dementia doesn't just take away memories – it can take away identity, connection, and the future you thought you had. 'Watching loved ones slip away, and not knowing why, is an experience no one should have to go through without answers. 'Many people across the UK are still waiting far too long for a dementia diagnosis – or never receive one at all. 'That means they miss out on vital support, on the chance to plan ahead, opportunities to get involved in research, and on precious time. 'A diagnosis may not fix everything, but it gives people understanding, clarity, and some control at a time when everything feels uncertain. It allows families to make the most of the moments they have left. 'That's why I've signed Alzheimer's Research UK's petition – and why I'm asking the public to do the same. 'Together, we can call on government to fix the crumbling diagnosis system and make sure no one faces dementia unseen.' The new Alzheimer's Research UK campaign, Dementia Unseen, comes after the NHS target to ensure 66.7% of people with dementia receive a diagnosis was removed from NHS planning guidance for 2025-26. Two breakthrough Alzheimer's drugs: lecanemab and donanemab, were rejected for use on the NHS last week. Alzheimer's Research UK is calling for people with suspected dementia to be referred by their GP to see a specialist within six weeks – and to have a diagnosis and treatment plan in place within 18 weeks. Hilary Evans-Newton, chief executive of Alzheimer's Research UK, said: 'Everyone who has dementia should have the right to know the disease or diseases causing it, and to be diagnosed early enough to get treatments that help with its symptoms. 'But hundreds of thousands of people are waiting too long for a diagnosis, causing uncertainty, and adding distress to an already challenging situation. 'We're incredibly grateful to Dame Judi for helping shine a light on what people with dementia need – and to everyone who has already signed our petition and stands with us. 'More people are seeking answers, so it's vital that the NHS and government act now to fix the system – because no one should face dementia alone or unseen.' Professor Fiona Carragher, chief policy officer at Alzheimer's Society, said: 'Everyone living with dementia deserves the clarity and dignity of an early and accurate diagnosis. Yet, more than a third of people living with this terminal condition are in the dark because they haven't been diagnosed, with many left to struggle alone without the care, support and treatment a diagnosis can bring. 'In fact, on average people experience dementia symptoms for three and a half years before they receive a diagnosis. 'For some time, we've been calling on the UK Government to urgently address dementia diagnosis and we welcome the recommendations in this new report. 'In particular, we support the call for health services to have the right teams and technology they need to diagnose more people, and for more data on diagnosis so that resources can be targeted where they're needed most. 'The science for dementia treatments is flying but the diagnosis system is failing. It is crucial governments invest in diagnosis across England, Wales and Northern Ireland so people can access the existing treatments of today, plan for the future, and be eligible for the life-changing treatments of tomorrow. 'If our governments set bold and ambitious new dementia diagnosis rate targets to get more people diagnosed, this would bring significant benefits for individuals, their families, and for health and care services.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country
Business News Wales
2 hours ago
- Business News Wales
Updated Bluetongue Guidance for Livestock Keepers
The Welsh Government has reinforced its commitment to protecting Welsh livestock from Bluetongue, a serious viral disease, with new disease control measures coming into effect in time for 1 July. To date, Wales has successfully kept Bluetongue serotype 3 (BTV-3) from circulating locally and remains BTV-3 free. Recognising the introduction of the England-wide Bluetongue Restricted Zone (RZ) from 1 July, Welsh Government is implementing updated movement controls to safeguard Welsh livestock. Bluetongue is a notifiable viral disease that impacts sheep, cattle, goats, deer, alpacas, and llamas and can have severe consequences for animal health and welfare, and farm incomes, causing illness, deaths, abortions, and birth defects, alongside significant movement restrictions and trade challenges. It is primarily spread by biting midges which are most active in the warmer months between April and November. Disease can also be spread by the movement of infected animals. Vaccines to protect livestock from the worst effects of Bluetongue are available and farmers are encouraged to consult their vet on whether they are appropriate for their herds and flocks. To ensure Welsh farm businesses are well-informed about this disease, Farming Connect will be hosting a webinar on Monday June 30 at 7:30pm. To register, contact the Farming Connect Service Centre, or CLICK HERE.
BBC News
2 hours ago
- BBC News
'Ageing' biosecurity labs in Surrey pledged £1bn for upgrade
The government has pledged to spend £1bn upgrading an animal health research centre in Department for Environment, Food and Rural Affairs (Defra) announced the investment in high-containment laboratories near Weybridge on National Audit Office (NAO) said in a June report the site, run by the Animal and Plant Health Agency (APHA), currently has a "very high" risk of site NAO also estimated the total cost of redeveloping the site would be £2.8bn. The government said the facilities will help manage animal disease outbreaks and the risk of future announcement followed the publication of a policy paper in March, which announced the development of a "national biosecurity centre" at the centre will "provide essential research, surveillance and outbreak response to help stop diseases" damaging the UK, according to the also announced £200m of funding in December for the APHA to upgrade biosecurity facilities at the Surrey announcement comes as part of a the UK's latest national security strategy. Farmers 'better protected' The government said work was already underway to redevelop the labs would be up and running in 2027 and 2028 while the national biosecurity centre was due to be fully operational is 2034, it Borough Council granted outline planning permission to redevelop the site in senior science director Jenny Stewart said Tuesday's announcement was a "vital milestone" in the funding will allow the agency's researchers to "continue their critical work in modern, fit-for-purpose facilities", she Secretary Steve Reed said: "Farmers and food producers will now be better protected from diseases, our food security strengthened, and public health better safeguarded against future pandemics." The Surrey site houses 98% of APHA high-containment laboratories, is its main long-term animal health studies site and is the the agency's only facility that can deal with most zoonotic diseases, according to the public spending watchdog warned in its report that the site is "in poor condition, with ageing buildings that need major repair and replacement".It added: "Any major failure at Weybridge could have potentially significant impacts on the UK."For example, APHA may not be able to deliver its emergency response during an outbreak."
